Clinical Trials Browser

Phase 1/2 × Breast Neoplasms × retrovector encoding mutant anti-cyclin G1 × Clear all

NCT00505271 2011-06-10

Safety and Efficacy Study Using Rexin-G for Breast Cancer

Phase 1/2 Completed

Breast Neoplasms